News

The trial has evaluated the potential of cethromycin to cause a prolongation in electrocardiographic QT interval. At the therapeutic and supratherapeutic doses, cethromycin showed no signal of any

This strategic relationship is expected to support company’s preparation for an investigational new drug application for Homspera. Efforts to be pursued at Lovelace will involve both the inhalational

Qscan-Clinical will include a database of marketed drug label data to assist in comparator study design and data analysis. Clients already using Qscan-ERM with their proprietary post-market safety

The Australian Register of Therapeutic Goods communicated its decision to approve the registration submitted by licensee Solvay Biosciences of Zan-Extra in its two dosage forms containing lercanidipine 10mg/enalapril

The patent-protected gene sequences have been tested as HIV vaccine candidates on 40 test persons by the EuroVacc Foundation in a Phase I clinical trial. In the trial,

Rami Eliakim, director of the Department of Gastroenterology at Rambam Medical Center, Haifa, Israel, said: “PillCam Colon offers a non-invasive alternative for individuals who cannot or do not

The aggregate gross proceeds from the common stock offering and the note offering, before commissions and expenses, are approximately $405.8 million.

The agreements between Novavax and Graceway provide for the sale of the patent associated with the product, the sale of other intellectual properties and assets, and the sale

The transaction, which is subject to customary closing conditions, is expected to be completed in the second calendar quarter of 2008.